Differential expression and function of nicotinic acetylcholine receptors in the urinary bladder epithelium of the rat

Journal of Physiology

Volumn 590, Issue 6, 2012, Pages 1465-1480

  Beckel, Jonathan M ^a   Birder, Lori A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BUNGAROTOXIN RECEPTOR; CALCIUM; CYCLIC AMP DEPENDENT PROTEIN KINASE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA3; PROTEIN KINASE C; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER EPITHELIUM; BLADDER FUNCTION; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; IN VIVO STUDY; MICTURITION REFLEX; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; RAT; RECEPTOR UPREGULATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; CALCIUM; CELLS, CULTURED; CYCLIC AMP-DEPENDENT PROTEIN KINASES; EPITHELIAL CELLS; FEMALE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; PURINERGIC ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; RECEPTORS, PURINERGIC; SIGNAL TRANSDUCTION; URINARY BLADDER; UROTHELIUM;

EID: 84858211033     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2011.226860     Document Type: Article

References (56)

1. Andersson KE (2002). Bladder activation: afferent mechanisms. Urology 59, 43-50.
2. Apodaca G, Balestreire E & Birder LA (2007). The uroepithelial-associated sensory web. Kidney Int 72, 1057-1064.
3. Beckel JM, Barrick SR, Keast JR, Meyers SA, Kanai AJ, de Groat WC, Zeidel ML & Birder LA (2004). Expression and function of urothelial muscarinic receptors and interactions with bladder nerves. Program No. 846.23. 2004 Neuroscience Meeting Planner. Society for Neuroscience, San Diego, CA, USA Online.
4. Beckel JM, Kanai A, Lee SJ, de Groat WC & Birder LA (2006). Expression of functional nicotinic acetylcholine receptors in rat urinary bladder epithelial cells. Am J Physiol Renal Physiol 290, F103-F110.
5. Birder LA (2010). Urothelial signaling. Auton Neurosci 153, 33-40.
6. Birder LA, Barrick SR, Roppolo JR, Kanai AJ, de Groat WC, Kiss S & Buffington CA (2003). Feline interstitial cystitis results in mechanical hypersensitivity and altered ATP release from bladder urothelium. Am J Physiol Renal Physiol 285, F423-F429.
7. Birder LA, Ruan HZ, Chopra B, Xiang Z, Barrick S, Buffington CA, Roppolo JR, Ford AP, de Groat WC & Burnstock G (2004). Alterations in P2X and P2Y purinergic receptor expression in urinary bladder from normal cats and cats with interstitial cystitis. Am J Physiol Renal Physiol 287, F1084-F1091.
8. Bodnar AL, Cortes-Burgos LA, Cook KK, Dinh DM, Groppi VE, Hajos, M, Higdon NR, Hoffmann WE, Hurst RS, Myers JK, Rogers BN, Wall TM, Wolfe ML & Wong E (2005). Discovery and structure-activity relationship of quinuclidine benzamides as agonists of α7 nicotinic acetylcholine receptors. J Med Chem 48, 905-908.
9. Bschleipfer T, Schukowski K, Weidner W, Grando SA, Schwantes U, Kummer W & Lips KS (2007). Expression and distribution of cholinergic receptors in the human urothelium. Life Sci 80, 2303-2307.
10. Burnstock G (2001). Purine-mediated signalling in pain and visceral perception. Trends Pharmacol Sci 22, 182-188.
11. Chan WK, Wong PT & Sheu FS (2007). Frontal cortical α7 and α4β2 nicotinic acetylcholine receptors in working and reference memory. Neuropharmacology 52, 1641-1649.
12. Chernyavsky AI, Arredondo J, Marubio LM & Grando SA (2004). Differential regulation of keratinocyte chemokinesis and chemotaxis through distinct nicotinic receptor subtypes. J Cell Sci 117, 5665-5679.
13. Conti-Fine BM, Navaneetham D, Lei S & Maus AD (2000). Neuronal nicotinic receptors in non-neuronal cells: new mediators of tobacco toxicity?. Eur J Pharmacol 393, 279-294.
14. Cook SP & McCleskey EW (2000). ATP, pain and a full bladder. Nature 407, 951-952.
15. Dajas-Bailador F & Wonnacott S (2004). Nicotinic acetylcholine receptors and the regulation of neuronal signalling. Trends Pharmacol Sci 25, 317-324.
16. Damaj MI, Fei-Yin M, Dukat M, Glassco W, Glennon RA & Martin BR (1998). Antinociceptive responses to nicotinic acetylcholine receptor ligands after systemic and intrathecal administration in mice. J Pharmacol Exp Ther 284, 1058-1065.
17. De Biasi M (2002). Nicotinic mechanisms in the autonomic control of organ systems. J Neurobiol 53, 568-579.
18. Dickinson JA, Kew JN & Wonnacott S (2008). Presynaptic α7- and β2-containing nicotinic acetylcholine receptors modulate excitatory amino acid release from rat prefrontal cortex nerve terminals via distinct cellular mechanisms. Mol Pharmacol 74, 348-359.
19. Exley R, Moroni M, Sasdelli F, Houlihan LM, Lukas RJ, Sher E, Zwart R & Bermudez I (2006). Chaperone protein 14-3-3 and protein kinase A increase the relative abundance of low agonist sensitivity human α4β2 nicotinic acetylcholine receptors in Xenopus oocytes. J Neurochem 98, 876-885.
20. Genzen JR, Van Cleve W & McGehee DS (2001). Dorsal root ganglion neurons express multiple nicotinic acetylcholine receptor subtypes. J Neurophysiol 86, 1773-1782.
21. ++ modulation of human neuronal α3 nicotinic receptors. J Pharmacol Exp Ther 286, 311-320.
22. Gwilt CR, Donnelly LE & Rogers DF (2007). The non-neuronal cholinergic system in the airways: an unappreciated regulatory role in pulmonary inflammation? Pharmacol Ther 115, 208-222.
23. Hanna-Mitchell AT, Beckel JM, Barbadora S, Kanai AJ, de Groat WC & Birder LA (2007). Non-neuronal acetylcholine and urinary bladder urothelium. Life Sci 80, 2298-2302.
24. Jeanclos EM, Lin L, Treuil MW, Rao J, DeCoster MA & Anand R (2001). The chaperone protein 14-3-3η interacts with the nicotinic acetylcholine receptor α4 subunit. Evidence for a dynamic role in subunit stabilization. J Biol Chem 276, 28281-28290.
25. Kesingland AC, Gentry CT, Panesar MS, Bowes MA, Vernier JM, Cube R, Walker K & Urban L (2000). Analgesic profile of the nicotinic acetylcholine receptor agonists, (+)-epibatidine and ABT-594 in models of persistent inflammatory and neuropathic pain. Pain 86, 113-118.
26. Khan IM, Wennerholm M, Singletary E, Polston K, Zhang L, Deerinck T, Yaksh TL & Taylor P (2004). Ablation of primary afferent terminals reduces nicotinic receptor expression and the nociceptive responses to nicotinic agonists in the spinal cord. J Neurocytol 33, 543-556.
27. 2+ responses in cultured urothelial cells from rat. Am J Physiol Renal Physiol 294, F971-F981.
28. Kullmann FA, Artim DE, Birder LA & de Groat WC (2008b). Activation of muscarinic receptors in rat bladder sensory pathways alters reflex bladder activity. J Neurosci 28, 1977-1987.
29. Kurzen H, Wessler I, Kirkpatrick CJ, Kawashima K & Grando SA (2007). The non-neuronal cholinergic system of human skin. Horm Metab Res 39, 125-135.
30. Lindstrom J, Anand R, Gerzanich V, Peng X, Wang F & Wells G (1996). Structure and function of neuronal nicotinic acetylcholine receptors. Prog Brain Res 109, 125-137.
31. Lips KS, Wunsch J, Zarghooni S, Bschleipfer T, Schukowski K, Weidner W, Wessler I, Schwantes U, Koepsell H & Kummer W (2007). Acetylcholine and molecular components of its synthesis and release machinery in the urothelium. Eur Urol 51, 1042-1053.
32. Macklin KD, Maus AD, Pereira EF, Albuquerque EX & Conti-Fine BM (1998). Human vascular endothelial cells express functional nicotinic acetylcholine receptors. J Pharmacol Exp Ther 287, 435-439.
33. McPherson PS, Kim YK, Valdivia H, Knudson CM, Takekura H, Franzini-Armstrong, C, Coronado R & Campbell KP (1991). The brain ryanodine receptor: a caffeine-sensitive calcium release channel. Neuron 7, 17-25.
34. Marchi M & Grilli M (2010). Presynaptic nicotinic receptors modulating neurotransmitter release in the central nervous system: functional interactions with other coexisting receptors. Prog Neurobiol 92, 105-111.
35. Marszalec W, Yeh JZ & Narahashi T (2005). Desensitization of nicotine acetylcholine receptors: modulation by kinase activation and phosphatase inhibition. Eur J Pharmacol 514, 83-90.
36. Nashmi R, Dickinson ME, McKinney S, Jareb M, Labarca C, Fraser SE & Lester HA (2003). Assembly of α4β2 nicotinic acetylcholine receptors assessed with functional fluorescently labeled subunits: effects of localization, trafficking, and nicotine-induced upregulation in clonal mammalian cells and in cultured midbrain neurons. J Neurosci 23, 11554-11567.
37. Nelson ME & Lindstrom J (1999). Single channel properties of human α3 AChRs: impact of β2, β4 and α5 subunits. J Physiol 516, 657-678.
38. Nishizaki T & Sumikawa K (1998a). Effects of PKC and PKA phosphorylation on desensitization of nicotinic acetylcholine receptors. Brain Res 812, 242-245.
39. Nishizaki T & Sumikawa K (1998b). Nicotinic receptors are regulated by protein kinase C activated via a nicotinic receptors-mediated signaling pathway. Brain Res Mol Brain Res 61, 211-218.
40. Pollock VV, Pastoor TE & Wecker L (2007). Cyclic AMP-dependent protein kinase (PKA) phosphorylates Ser362 and 467 and protein kinase C phosphorylates Ser550 within the M3/M4 cytoplasmic domain of human nicotinic receptor α4 subunits. J Neurochem 103, 456-466.
41. Ribeiro-da-Silva A & Cuello AC (1990). Choline acetyltransferase-immunoreactive profiles are presynaptic to primary sensory fibers in the rat superficial dorsal horn. J Comp Neurol 295, 370-384.
42. Ruan HZ, Birder LA, de Groat WC, Tai C, Roppolo J, Buffington CA & Burnstock G (2005). Localization of P2X and P2Y receptors in dorsal root ganglia of the cat. J Histochem Cytochem 53, 1273-1282.
43. Santoso AGH, Sonarno IAB, Arsad NAB & Liang W (2010). The role of the urothelium and ATP in mediating detrusor smooth muscle contractility. Urology 76, 1267.e7-1267.e12.
44. Schaafsma HE, Ramaekers FC, van Muijen GN, Ooms EC & Ruiter DJ (1989). Distribution of cytokeratin polypeptides in epithelia of the adult human urinary tract. Histochemistry 91, 151-159.
45. Singh A, Potter A & Newhouse P (2004). Nicotinic acetylcholine receptor system and neuropsychiatric disorders. IDrugs 7, 1096-1103.
46. Summers AE, Whelan CJ & Parsons ME (2003). Nicotinic acetylcholine receptor subunits and receptor activity in the epithelial cell line HT29. Life Sci 72, 2091-2094.
47. Sun X, Liu Y, Hu G & Wang H (2004). Activities of cAMP-dependent protein kinase and protein kinase C are modulated by desensitized nicotinic receptors in the rat brain. Neurosci Lett 367, 19-22.
48. Troyanovsky SM, Leube RE & Franke WW (1992). Characterization of the human gene encoding cytokeratin 17 and its expression pattern. Eur J Cell Biol 59, 127-137.
49. Vizi ES & Lendvai B (1999). Modulatory role of presynaptic nicotinic receptors in synaptic and non-synaptic chemical communication in the central nervous system. Brain Res Brain Res Rev 30, 219-235.
50. Wessler I, Kirkpatrick CJ & Racke K (1998). Non-neuronal acetylcholine, a locally acting molecule, widely distributed in biological systems: expression and function in humans. Pharmacol Ther 77, 59-79.
51. Wessler IK & Kirkpatrick CJ (2001). The non-neuronal cholinergic system: an emerging drug target in the airways. Pulm Pharmacol Ther 14, 423-434.
52. Wonnacott S (1997). Presynaptic nicotinic ACh receptors. Trends Neurosci 20, 92-98.
53. Yoshida M, Inadome A, Maeda Y, Satoji Y, Masunaga K, Sugiyama Y & Murakami S (2006). Non-neuronal cholinergic system in human bladder urothelium. Urology 67, 425-430.
54. Yoshida M, Miyamae K, Iwashita H, Otani M & Inadome A (2004). Management of detrusor dysfunction in the elderly: changes in acetylcholine and adenosine triphosphate release during aging. Urology 63, 17-23.
55. Yu Y & de Groat WC (2008). Sensitization of pelvic afferent nerves in the in vitro rat urinary bladder-pelvic nerve preparation by purinergic agonists and cyclophosphamide pretreatment. Am J Physiol Renal Physiol 294, F1146-F1156.
56. Zarghooni S, Wunsch J, Bodenbenner M, Bruggmann D, Grando SA, Schwantes U, Wess J, Kummer W & Lips KS (2007). Expression of muscarinic and nicotinic acetylcholine receptors in the mouse urothelium. Life Sci 80, 2308-2313.